13
report
Envisioning a Trusted System for Health Data Accelerating Medical Research
Technological innovation in the health landscape is occurring rapidly, and much of it would not be
possible without patient data.
+ Read More
report
Alzheimer's Disease: A Giving Smarter Guide to Accelerate Development of New Therapies
The need is staggering. Alzheimer's disease is the sixth leading cause of death in the United State
s and currently, more than 5.5 million Americans are living with this disease for which there is yet no cure yet.
+ Read More
report
Funding Scientific Research - A Giving Smarter Guide
Making an Impact. Strategic philanthropic investments in medical research require a careful conside
ration of the philanthropist’s priorities and an understanding of the current state of research to amplify the impact of their giving.
+ Read More
report
Models for Biomedical Innovation and Commercialization
This report relates to a Financial Innovations Lab held in Jerusalem in 2015 that led to new work a
nd major collaborative projects between the Milken Innovation Center and universities in the U.S..
+ Read More
report
Financing the Control of Tuberculosis
As of 2015, roughly one third of the world’s population, mostly in poorer countries, carried tuberc
ulosis bacteria in their system. Given the characteristics of airborne diseases like tuberculosis, coordination among national and international age
+ Read More
report
Expanding the Science of Patient Input: Building Smarter Patient Registries
Decision-makers in research, industry, policy and health-care settings are actively seeking robust
sources of patient data to inform patient-centered practices, policies and outputs.
+ Read More
report
Rx for Innovation: Recommendations for the New Administration
FasterCures wants President-elect Donald Trump to be ready to address biomedical innovation on day
one.
+ Read More
report
Glioblastoma Multiforme: A Giving Smarter Guide to Accelerating Research Progress
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the b
rain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe.
+ Read More
report
Expanding the Science of Patient Input: The Power of Language
Language matters.
video
Toward a Healthier Future
Conventional wisdom often suggests that a nation's health is a byproduct of its wealth.
video
Outsmarting Superbugs: What Are the Alternatives?
The challenges in developing new antibiotics have left us vulnerable to growing antimicrobial resi
stance. The lack of investment and slow movement in the development pipeline mean no replacements for ineffective antibiotics as drug resistance spreads.
+ Read More
article
Who Gains More From Medical Innovation: Patients Or Drug Manufacturers?
The social value of any production activity (e.g., a new drug) is the value consumers place on the p
roduct beyond the cost or resources involved in the product’s manufacturing.
+ Read More